Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 1.34% today. In the last week its performance is 7.00%, and -7.18% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 333.47, so today’s gain of 1.34% is a significant step towards its target price. The GAP today is therefore 0.31%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 53643.63, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.50%.
At the current price of 245.06, it has a dividend yield of *TBA, and its target price is 333.47. This is with a profit margin of 33.80%, and total debt/equity of 0.63. Biogen Inc. (NASDAQ:BIIB) has a P/E of 15.05, as well as a forward P/E of 12.18.
With a current EPS of 16.28, and a forecasted EPS growth for next year at 6.66%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 7.80%.
Performance for the year is -39.38%. Since its IPO date on 9/17/1991, the total performance to date is -20.01%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1465335, while its average volume is 1872.65. Whilst the total gain today was 1.34%, it did have a day high of -16.27%.
Volatility for this week has been at 2.47%, and 2.46% for the month. The 52-week low for Biogen Inc., BIIB has been 9.88%, while the 52-week-high has reached -40.55%.
Looking at its return of investments, which is 23.50%, and its return on assets is 19.00%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.10%. With a sales growth of 6.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.63, and has a current ratio of 2.6 and 2.2 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 1.93, and the P/S is 4.91, along with a P/B of 5.19. Meanwhile it has a p/cash of 14.96.